NEWSWIRETODAY Press Release& Newswire Distribution | HOME
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Alto Marketing Ltd
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Safe Intelligent Haematology Auto-validation at Airedale - HORIBA Medical wins second five-year tender for high throughput, routine haematology
Safe Intelligent Haematology Auto-validation at Airedale


NewswireToday - /newswire/ - Northampton, United Kingdom, 2009/09/29 - HORIBA Medical wins second five-year tender for high throughput, routine haematology.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


One year on from rewarding a new five-year contract to HORIBA Medical for two new ABX Pentra DX 120 haematology analysers and accompanying ABX Pentra ML data management software, Airedale General Hospital has significantly improved auto-validation procedures for haematology results. With over 60% of all results now being safely and intelligently validated automatically, this has freed up staff time significantly, whilst also improving turnaround times and service levels.

In reviewing its requirements for new routine haematology analysers, the pathology laboratory at Airedale General Hospital recognised the need to implement smooth working practices in order to ensure the best use of valuable staff time. IT-based solutions ensuring efficient data management and subsequent automatic results validation were considered a key differentiator in the Trust’s tender selection process.

“Having already been working with HORIBA Medical for a number of years, we were very impressed by the reliable work horse solutions that our previous ABX Pentra high throughput haematology analysers had proven to be. In addition, HORIBA Medical ( has also always provided us with an excellent level of customer service and training support,” explained Dr Afruj Ali Ruf, Consultant Healthcare Scientist. “We did now however need a greater degree of data management support and the ABX Pentra ML was the most flexible data manager that we had seen, giving us the greatest scope to safely develop our auto-validation capabilities.”

Adapting the ABX Pentra ML to meet the specific requirements at Airedale was a relatively simple process since the Hospital had already developed basic rules based validation with the previous system. “Having already established our groupings of normal blood count ranges, such as for pregnant and post operative patients based on our historical data, we were able to confidently and quickly implement intelligent auto-validation procedures using the ABX Pentra ML,” continued Dr Ruf. “The ABX Pentra ML was very simple to configure to recognise such groupings and apply the necessary normal ranges.”

The ability to easily develop rules based on certain clinical details, clinicians, or even samples from a certain location, as well as good IT links to haematology clinics has meant that the majority of results can now be delivered in real time. Faster turnaround times (TATs) have improved levels of service for patients who may have had to travel long distances to attend clinics. Airedale covers the greatest geographical area of all UK NHS Trusts and encompasses three Primary Care Trusts crossing the Yorkshire/Lancashire border!

“Now that we have our normal ranges confidently established within the ABX Pentra ML, our auto-validation procedures now only ever intelligently flag truly abnormal results. This gives our experienced staff more time to proactively investigate these further to provide more in depth clinically relevant results,” added Dr Ruf. “Having already achieved a 60% auto-validation rate is fantastic, but we know that we can work with HORIBA Medical to make our ABX Pentra ML work even harder for us. Since our staffing levels are finite but our workload isn’t, we’re now looking to develop further rules.”

In addition to the two ABX Pentra ML validation stations in the main laboratory, a satellite ABX Pentra ML validation station has also been installed remotely from the routine laboratory, next to the microscopes used for the examination of blood films. This means that comments on blood films made for abnormal samples can be typed and uploaded directly to the LIMS. This not only enables sample validation at the site of the microscope to further increase TATs, but it also minimises opportunity for transcription errors. In addition, it also assists workflow since laboratory personnel always know exactly at which stage in the analytical process a sample is.

“All of this workflow enhancement really can only be achieved with a readily configurable data management system and a company happy to work in partnership with us, both of which we have found in the ABX Pentra ML and HORIBA Medical,” concluded Dr Ruf. “Having such a flexible data management system is really helping us towards ‘LEANing’ our result validation process.”

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Alto Marketing Ltd


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick NewswireToday Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Safe Intelligent Haematology Auto-validation at Airedale

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
Publisher Contact: Leigh Dilley - 
+44(0)14 8955 7672 catherines[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Alto Marketing Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Alto Marketing Ltd / Company Profile

Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer
Antibiotic Alternatives Stimulate New Product Development in Global Animal Feed Ingredient Market Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  RightITnow, Inc.


  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (